Full name
CENTRUM GINEKOLOGII ENDOKRYNOLOGII I MEDYCYNY ROZRODU "ARTEMIDA" DOMITRZ I PARTNERZY SPÓŁKA PARTNERSKA LEKARZY
uses securityreCAPTCHA
86.21.Z - General medical practice
47.73 - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
59.20.Z - Sound recording and music publishing activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
86.10.Z - Hospital activities
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,6 | 0,6 | -8,7 |
EBITDA | 0,8 | 0,6 | 0,7 | 4,9 |
Short time liabilities | 0,3 | 0,4 | 0,4 | 6,5 |
Equity capital | 2,4 | 2,9 | 2,7 | -7,5 |
Operating profit (EBIT) | 0,8 | 0,5 | 0,6 | 8,3 |
Assets | 2,8 | 3,3 | 3,1 | -6,2 |
Net profit (loss) | 0,8 | 0,6 | 0,6 | -8,7 |
Cash | 1,1 | 1,2 | 0,9 | -29,4 |
Net income from sale | 5,5 | 5,5 | 5,9 | 6,5 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,4 | 3,5 |
Working assets | 1,2 | 1,3 | 1 | -20,2 |
Depreciation | 0,1 | 0,1 | 0,1 | -11,3 |
% | % | % | p.p. | |
Profitability of capital | 33,1 | 22,1 | 21,8 | -0,3 |
Equity capital to total assets | 86,9 | 88,2 | 87 | -1,2 |
Gross profit margin | 14,7 | 11,6 | 9,9 | -1,7 |
EBITDA Margin | 15,4 | 11,6 | 11,4 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 20 | 25 | 25 | 0 |
Current financial liquidity indicator | 3.2172868251800537 | 3.276479482650757 | 2.5255327224731445 | -0,8 |
Net dept to EBITDA | -1.2460271120071411 | -1.888490080833435 | -1.279447078704834 | 0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane